Abbott India Limited (BOM: 500488)

India flag India · Delayed Price · Currency is INR
29,772
-113 (-0.38%)
At close: Sep 10, 2024
29.10%
Market Cap 632.64B
Revenue (ttm) 59.28B
Net Income (ttm) 12.39B
Shares Out 21.25M
EPS (ttm) 583.08
PE Ratio 51.06
Forward PE n/a
Dividend 410.00 (1.38%)
Ex-Dividend Date Jul 19, 2024
Volume 284
Open 30,001
Previous Close 29,885
Day's Range 29,727 - 30,273
52-Week Range 21,907 - 30,500
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About Abbott India

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a... [Read more]

Industry Pharmaceutical Preparations
Founded 1910
Employees 3,814
Stock Exchange Bombay Stock Exchange
Ticker Symbol 500488
Full Company Profile

Financial Performance

In 2023, Abbott India's revenue was 58.49 billion, an increase of 9.35% compared to the previous year's 53.49 billion. Earnings were 12.01 billion, an increase of 26.52%.

Financial Statements

News

Stocks Hitting 52-Week Highs Today: Trent, TVS Motor, Abbott India and others

Several stocks reached new 52-week highs in today’s market on August 22, showcasing strong performances across different sectors. Trent Ltd: Fashion retailer Trent Ltd touched a 52-week high at Rs 6,9...

20 days ago - Business Upturn